Shares of Proto Labs, Inc. (NYSE:PRLB - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six analysts that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $100.50.
A number of analysts have recently issued reports on the stock. William Blair reiterated a "market perform" rating on shares of Proto Labs in a report on Monday, November 2nd. Zacks Research lowered Proto Labs from a "strong-buy" rating to a "hold" rating in a research report on Friday, October 2nd. Cantor Fitzgerald reiterated an "overweight" rating on shares of Proto Labs in a report on Tuesday, October 27th. Needham & Company LLC upped their target price on shares of Proto Labs from $87.00 to $110.00 and gave the stock a "buy" rating in a research note on Friday, October 23rd. Finally, Weiss Ratings raised shares of Proto Labs from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday.
View Our Latest Report on PRLB
Insider Transactions at Proto Labs
In related news, Director Rainer Gawlick acquired 720 shares of the stock in a transaction on Tuesday, November 3rd. The stock was purchased at an average price of $68.18 per share, for a total transaction of $49,089.60. Following the completion of the transaction, the director owned 46,813 shares of the company's stock, valued at $3,191,710.34. This trade represents a 1.56% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Suresh Krishna bought 750 shares of the firm's stock in a transaction on Monday, November 2nd. The stock was purchased at an average cost of $69.52 per share, with a total value of $52,140.00. Following the completion of the acquisition, the chief executive officer directly owned 30,897 shares of the company's stock, valued at approximately $2,147,959.44. The trade was a 2.49% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders have sold 10,000 shares of company stock worth $902,629. Company insiders own 1.30% of the company's stock.
Hedge Funds Weigh In On Proto Labs
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Zacks Investment Management raised its holdings in shares of Proto Labs by 4.8% during the third quarter. Zacks Investment Management now owns 55,546 shares of the industrial products company's stock worth $5,269,000 after purchasing an additional 2,557 shares during the last quarter. Algert Global LLC grew its holdings in shares of Proto Labs by 129.3% during the 3rd quarter. Algert Global LLC now owns 84,155 shares of the industrial products company's stock worth $7,982,000 after purchasing an additional 47,460 shares during the period. Allworth Financial LP lifted its holdings in shares of Proto Labs by 151.1% in the 3rd quarter. Allworth Financial LP now owns 339 shares of the industrial products company's stock worth $32,000 after acquiring an additional 204 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Proto Labs by 15.2% in the 3rd quarter. Goldman Sachs Group Inc. now owns 464,341 shares of the industrial products company's stock valued at $44,043,000 after acquiring an additional 61,162 shares in the last quarter. Finally, K2 Principal Fund L.P. acquired a new position in shares of Proto Labs during the third quarter worth about $379,000. Hedge funds and other institutional investors own 84.54% of the company's stock.
Proto Labs Stock Down 8.6%
Proto Labs stock opened at $57.47 on Friday. The firm has a 50-day moving average price of $82.17 and a two-hundred day moving average price of $73.99. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of 40.19 and a beta of 1.52. Proto Labs has a 52-week low of $46.88 and a 52-week high of $99.96.
Proto Labs (NYSE:PRLB - Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The industrial products company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.60 by $0.03. The company had revenue of $154.32 million for the quarter, compared to analyst estimates of $149.31 million. Proto Labs had a net margin of 6.04% and a return on equity of 5.40%. Proto Labs's quarterly revenue was up 13.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.47 EPS. Research analysts expect that Proto Labs will post 1.52 earnings per share for the current year.
Proto Labs Company Profile
(
Get Free Report)
Proto Labs, Inc. is a digital manufacturing company that helps businesses make custom parts for product development and production. Its services connect customers with manufacturing capabilities through an online platform, supporting projects from prototypes to production runs. The company offers injection molding, computer numerical control (CNC) machining, 3D printing and sheet metal fabrication. Customers can submit designs online for review and receive quotes and feedback intended to help them assess and refine parts before manufacturing.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.